Carlos Bonilla
Corporate Officer/Principal at Carlos J. Bonilla & Associates PL
Net worth: 1 M $ as of 2024-05-30
Carlos Bonilla active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 2011-05-11 | - |
Career history of Carlos Bonilla
Former positions of Carlos Bonilla
| Companies | Position | Start | End |
|---|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Director/Board Member | 2011-03-24 | - |
| Independent Dir/Board Member | 2011-03-23 | - |
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Stock Market
- Insiders
- Carlos Bonilla
- Experience
